💊 Zydus & Sunshine Healthcare Launch US$ 20Mn+ Pharma JV in Sri Lanka

⚡ Zydus Lifesciences and Sunshine Healthcare have announced a strategic joint venture—Zydus Sunshine Lifesciences Pvt Ltd—investing over US$ 20 million to establish a pharmaceutical manufacturing facility in Sri Lanka. • Investment & Location: Over US$ 20 million committed to build a plant on nearly four acres of land at the Board of Investment (BOI) zone in Horana. The foundation stone was laid today. • Economic Impact: The venture aims to boost domestic production in the healthcare & pharmaceuticals sector, reducing import dependence, enhancing supply security, and creating skilled employment. • Strategic Roles: Combines Zydus' global technical expertise in formulations and APIs (Active Pharmaceutical Ingredients) with Sunshine’s local distribution capabilities. • Market Focus: The plant will manufacture products for Sri Lanka's retail market, focusing on improving the availability and affordability of essential medicines under NMRA regulations.